¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼¼ºê¶õ½ºº´¿ø Next Generation Precision medicine: Bridging biology and drug development in precision oncology : 2019-11-01

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¼¼ºê¶õ½ºº´¿ø Next Generation Precision medicine: Bridging biology and drug development in precision oncology : 2019-11-01
±³À°ÀÏÀÚ : 2019-11-01
±³À°Àå¼Ò : ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿¡ºñ½¼ÀÇ»ý¸í¿¬±¸¼¾ÅÍ 1Ãþ À¯ÀÏÇÑ È¦  
±³À°ÁÖÁ¦ : Next Generation Precision medicine: Bridging biology and drug development in precision oncology
ÁÖÃÖ±â°ü : ¼¼ºê¶õ½ºº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ³»°ú  
´ã´çÀÚ : ÀÌÁ¤Àº
¿¬¶ôó : 02-2228-0613  
À̸ÞÀÏ : jelee220@yuhs.ac      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 30,000¿ø      
ºñ°í ¡Þ ¼ö°­·á: 20,000¿ø (»çÀüµî·Ï ±âÁØ)  -¿¬¼¼ÀÇ·á¿ø Á÷¿ø ¹× Çлý ¹«·á  -¿ÜºÎÀÎ °æ¿ì¿¡µµ ÇлýÀº ¹«·á  -±âŸÀÇ °æ¿ì¿¡´Â ¼ö°­·á ¡¼ö. ÇöÀåµî·Ï½Ã 3¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 11-01 ABMRC À¯ÀÏÇÑȦ 09:00~09:10 Opening and Welcome Address  () 
±³À°½Ã°£ 11-01 ABMRC À¯ÀÏÇÑȦ 09:10~09:30 Employing the dual nature of T cells for immunotherapy  Yoon Park(KIST, Korea) 
±³À°½Ã°£ 11-01 ABMRC À¯ÀÏÇÑȦ 09:30~09:50 NK cell-based immunotherapy for refractory cancer  In Pyo Choi(KRIBB, Korea) 
±³À°½Ã°£ 11-01 ABMRC À¯ÀÏÇÑȦ 09:50~10:30 Cancer genomics landscape for precision medicine and the future  Alex Boussioutas(The University of Melbourne, Australia) 
È޽Ġ11-01 ABMRC À¯ÀÏÇÑȦ 10:30~10:50   () 
±³À°½Ã°£ 11-01 ABMRC À¯ÀÏÇÑȦ 10:50~11:20 Heading towards the SUMMIT of HER2 Mutations: Moving Cancer Knowledge Past HER2 Amplification  Michael Cox(Puma Biotechnology, Inc., USA) 
±³À°½Ã°£ 11-01 ABMRC À¯ÀÏÇÑȦ 11:20~11:50 Merck¡¯s approach to precision medicine in oncology  Peter Tobin(Merck-Serono Co. Ltd., USA) 
±³À°½Ã°£ 11-01 ABMRC À¯ÀÏÇÑȦ 11:50~13:00 New Era of Systemic Chemotherapy for Advanced Gastric Cancer  Narikazu Boku(National Cancer Hospital, Japan) 
±³À°½Ã°£ 11-01 ABMRC À¯ÀÏÇÑȦ 13:00~13:20 The promise of combining radiation therapy and immunotherapy  Jee Suk Chang(Yonsei University College of Medicine, Korea) 
±³À°½Ã°£ 11-01 ABMRC À¯ÀÏÇÑȦ 13:20~13:50 The BiTE¢ç immuno-oncology platform and its potential application in gastric Cancer  Virginie Naegele(Amgen Research (Munich) GmbH, Germany) 
±³À°½Ã°£ 11-01 ABMRC À¯ÀÏÇÑȦ 13:50~14:10 Exosomes and mimetic technologies for theranostics  Yong Song Gho(POSTECH, Korea) 
±³À°½Ã°£ 11-01 ABMRC À¯ÀÏÇÑȦ 14:10~14:30 AI and Precision Medicine: Data-driven drug response prediction and drug discovery  Jae Woo Kang(Korea University, Korea) 
È޽Ġ11-01 ABMRC À¯ÀÏÇÑȦ 14:30~14:50   () 
±³À°½Ã°£ 11-01 ABMRC À¯ÀÏÇÑȦ 14:50~15:40 GI network, Omics, Georgetown  John Marshall(Georgetown University Hospital, USA) 
±³À°½Ã°£ 11-01 ABMRC À¯ÀÏÇÑȦ 15:40~16:00 Novel IO response predictive biomarker :  Alex Boussioutas(The University of Melbourne, Australia) 
±³À°½Ã°£ 11-01 ABMRC À¯ÀÏÇÑȦ 16:00~16:30 Anti-drug Ab with immune-oncologic agent in melanoma and lung cancer  Aaron Ha(Sengenics Co., Ltd., Singapore) 
±³À°½Ã°£ 11-01 ABMRC À¯ÀÏÇÑȦ 16:30~17:00 Epigenetic predictive biomarker of IO treatment  Raghav Sundar(National University Hospital, Singapore) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼¼ºê¶õ½ºº´¿ø Next Generation Precision medicine: Bridging biology and drug development in precision oncology : 2019-11-01""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2019 ´ëÇѳ»ºÐºñÇÐȸ Çп¬»ê ¹× Ãß°èÇмú´ëȸ : 2019-11-01
´ÙÀ½±Û ´ëÇÑ¿Ü°úÇÐȸ Annual Congress of KSS 2019 (71Â÷ Ãß°èÇмú´ëȸ) : 2019-11-01
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 37 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 35 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 31 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 27 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 32 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 49 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 17 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 27 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 24 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 24 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 24 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 21 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 23 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 28 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 28 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷